1. Abdel-Wahab AF, Fathy O, Al-Harizy R. Negative correlation between fetuin-A and indices of vascular disease in systemic lupus erythematosus patients with and without lupus nephritis. Arab J Nephrol Transpl. 2013;6:11–20.
2. Afsar CU, Uzun H, Yurdakul S, et al. Association of serum fetuin-A levels with heart valve calcification and other biomarkers of inflammation among persons with acute coronary syndrome. Clin Invest Med. 2012;35:E206–15.
3. Akyuz A, Oran M, Alpsoy S, et al. Association between serum fetuin-a levels, carotid artery stiffness, and intima-media thickness in patients with normotensive obstructive sleep apnea syndrome. Angiology. 2013;65:607–13.
4. Alpsoy S, Akyuz A, Mutlu LC, et al. Serum fetuin-A levels are associated with carotid intima-media thickness in patients with normotensive chronic obstructive pulmonary disease. Cardiol J. 2014;21:191–7.
5. Auberger P, Falquerho L, Contreres JO, et al. Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity. Cell. 1989;58:631–40.